Lemon Balm for Insomnia

Lemon balm shortens the wind-down period and improves subjective sleep onset in small trials, usually at 300-600 mg of standardised extract in the evening. It is gentle, fast-acting and backed by a genuinely thin evidence base.

Rosmarinic acid inhibits GABA transaminase, the enzyme that breaks down GABA, raising central GABA availability. The result is reduced pre-sleep arousal rather than direct sedation, which is why it eases sleep onset without producing next-morning grogginess.

The clinical literature is small. Randomised placebo-controlled studies of standardised lemon balm extract at 300-600 mg/day report improvements in subjective sleep quality and reductions in anxiety and insomnia scores, typically in participants with mild to moderate disturbance rather than diagnosed insomnia. Several of the better-known trials used a fixed combination with valerian, including studies in children with restlessness and sleep difficulty, which makes the independent contribution of lemon balm hard to isolate. Mechanistic work is more solid than the clinical work: lemon balm extract inhibits GABA transaminase in enzyme assays in a dose-dependent manner, giving a plausible route to the observed calming effect. No large trial has tested lemon balm alone against an active hypnotic, and polysomnographic data are largely absent, so claims rest on subjective endpoints.

People whose sleep onset problem is driven by delayed sleep phase, stimulant use, sleep apnoea or a diagnosed anxiety disorder — the effect size here is too small to overcome those.